Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

sigma-tau is one of the most important Italian pharmaceutical groups, with a major presence also on the international stage. For more than half a century the company has been active in promoting the quality of life of man and his health. sigma-tau is present today in the most advanced research sectors, maintaining constant relations with scientific institutions with a world-wide reputation in the development of joint projects and in the implementation of original and innovative research programs. These results are the fruit of substantial, ongoing investment in research in the field of pharmaceutical innovation and stem not only from the efforts made to produce new products but also from the success of the company’s consolidated products. Bearing witness to sigma-tau’s achievements are not only the principles and values that inspire our efforts - innovation, dialogue and transparency, ethics, sustainability - but also the facts that have made sigma-tau a leading company in the research, manufacture and marketing of drugs.

Creo Medical Ltd. develops, manufactures and commercializes medical device technologies. It offers CROMA system, an electrosurgical unit that delivers bipolar radiofrequency power for the purpose of cutting, and microwave power for the purpose of coagulating tissue to staunch bleeding vessels. The firm also offers RS2 instrument, a retractable injection needle for tissue lift and irrigation. The company was founded by Christopher Paul Hancock and Steven Morris in 2003 and is headquartered in Chepstow, the United Kingdom.

MerLion Pharmaceuticals.drug discovery and development company, engages in the research and development of natural products. It operates through two business units, MerLion Research and MerLion Development. The MerLion Research unit is a contract services business, which provides access to natural product collections by offering sample/extract supply services, extract profiling and standardization, assay development, throughput screening, compound purification and structural identification, biocatalyst isolation, and strain improvement. The MerLion Development unit is progressing finafloxacin, a differentiated antibacterial candidate through phase II clinical trials, which is targeted initially for the eradication of Helicobacter pylori and treatment of urinary tract infections. It also provides portfolio of earlier-stage, preclinical antibacterial, and oncology programmes. The company serves pharmaceutical, industrial biotechnology, agro science, food and flavorings, cosmetics, and personal healthcare companies. MerLion Pharmaceuticals Pte. Ltd. was founded in 2002 and is based in Singapore, Singapore with clinical development operations in Berlin, Germany.

Indena is the world’s leading company in the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health-food and personal care industries.Indena, a privately owned Italian company, has around 800 employees (10% of them dedicated to full-time research) and has cultivation, manufacturing, and sales in more than 70 countries throughout the world.

Unitika Ltd. engages in the polymer and functional materials business. It operates through the following business segments: Polymer, Functional Material, Fiber, and Others. The Polymer segment manufactures and sells plastic film, resin, and non-woven cloth. The Functional Material segment handles the manufacture and sale of glass fibers. The Fiber segment deals with the manufacture and sale of various fibers such as thread, cotton, and knitted fibers. The Others segment includes environmental business, medical business, lifestyle and wellness, and real estate businesses. The company was founded on June 19, 1889 and is headquartered in Osaka, Japan.

Part of Novartis AG, Sandoz AG is a Swiss company located in Basel. The firm develops generic medicines and biosimilars.

COWAY Co., Ltd. engages in the manufacture and sale of household electronic appliances. It operates through the following business divisions: Rental, Lump-Sum Payment, and Others. Its products include water purifiers, air purifiers, bidet, water softeners, and mattresses. The company was founded on May 22, 1989 and is headquartered in Gongju-si, South Korea.

Probionov SA is a private company headquartered in Clermont-Ferrand, France. The firm manufactures and supplies drugs.

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutics targeting serious bacterial infections. Its lead program addresses a novel target driving virulence and persistence of pseudomonas aeruginosa infections and other gram-negative pathogens.

Melinta Therapeutics is an antibiotics-focused company. The company’s mission is to discover, develop and commercialize urgently needed, groundbreaking antibiotics to overcome drug-resistant, life-threatening infections. The need for new therapies for drug-resistant infections is widely recognized as one of the most serious public health issues facing the world today. To meet this need, Melinta Therapeutics is rapidly progressing its late-stage investigational antibiotic, delafloxacin, which is currently in Phase 3 development for acute bacterial skin and skin structure infections (ABSSSI). In addition, Melinta is focused on its ongoing research program to develop a new class of antibiotics designed to overcome the resistant ESKAPE pathogens known to cause the majority of serious hospital infections and patient deaths. Melinta Therapeutics is privately held and backed by Vatera Healthcare Partners and Warburg Pincus.

Yakult Honsha Co., Ltd. engages in the manufacture and sale of food and beverage products, cosmetics, and pharmaceuticals. It operates through the following segments: Food and Beverages in Japan, the Americas, Asia and Oceania, and Europe; Pharmaceuticals, and Others. The Food and Beverages segment produces and merchandises milk drinks, noodles, juices, and soft drinks. The Pharmaceuticals segment manufactures and sells anti-cancer drugs and other pharmaceutical products. The Others segment includes cosmetics and professional baseball team management. The company was founded by Minoru Shirota in 1935 and is headquartered in Tokyo, Japan.

Ruishengde (Guangzhou) Technology Co., Ltd., established on 2019-04-01, Business scope includes agricultural scientific research and experimental development;Food Science and Technology Research Services;Medical technology research and development;Biomedical Technology Research;Medical Research and Experimental Development;Commodity wholesale trade(Except for licensed and approved products);Wholesale of cosmetics and hygiene products;Cosmetics Wholesale;Retailing of cosmetics and hygiene products;Cosmetics Retail;Realtor;Sales of chemical reagents and auxiliaries(Monitor Chemicals,Excluding hazardous chemicals);Biotechnology Consulting,communication service;Information Technology Consulting Services;Real Estate Consulting Services;Business Management Consulting Services;Educational Consulting Services;Import and export(Excluding franchised products);Technology Import and Export;Medical technology promotion service;Medical Technology Consulting,communication service;Medical technology transfer service;Market Research Services;Marketing Planning Service;Acquisition of agricultural and sideline products;Agricultural technology extension service;Agricultural Technology Development Services;Agricultural Technology Consulting,communication service;Agricultural technology transfer service;

Guangzhou Baiyunshan Baidi Bio-Pharmaceutical Co., Ltd., established on 2001-08-27, Business scope includes medical research and experimental development;R&D and application of cell technology;Biochemical product technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Wholesale;Sales of hygiene products and single-use medical products;Non-residential real estate leases;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Manufacturing of plastic products;Disinfectant sales(Free of Hazardous Chemicals);Sales of Class I Medical Devices;Production of Class I Medical Devices;Sales of Class II Medical Devices;Indoor Sanitation Insecticide Sales;Pet Food and Supplies Wholesale;Animal Husbandry and Fishery Feed Sales;internet sales(Except for products that require a license for sale);Home Appliance Sales;Intelligent robot sales;Food Internet Sales(Only sell prepackaged food);pharmaceutical production;Cosmetic production;food sales;Import and export;Technology Import and Export

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Superior Medical Ltd. provides health care services. Its services include general medical supply, allied health care, women’s health, patient education and material. The company was founded in 1970 and is headquartered in Downsview, Canada.

Ningguo Jisi Intellectual Property Operation Co., Ltd., established on 2020-09-16, Business scope includes intellectual property agency services;Intellectual Property Consulting Services;Patent agency and consulting services;Trademark agency and consulting services;Branding;Project report;Computer software and hardware development;Network technology development;computer system integration;design,make,acting,Place an ad.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)